APM
SANA icon

Avidity Partners Management’s Sana Biotechnology SANA Stock Holding History

Avidity Partners Management’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-774,644
Closed -$17.4M – 110
2021
Q3 		$17.4M Sell
774,644
-3,953
-0.5% -$83K 0.39% 58
2021
Q2 		$15.3M Buy
778,597
+46,276
+6% +$1.05M 0.41% 60
2021
Q1 		$24.5M Buy
+732,321
New +$23.8M 0.68% 51

Other funds holding SANA

FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Public Sector Pension Investment Board (PSP Investments)
Public Sector Pension Investment Board (PSP Investments) Montreal, Quebec, Canada $38.7B AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CM
Crestline Management Fort Worth, Texas $53.5M AUM 80.67% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return

Avidity Partners Management's SANA Position: Q4 2021 in Review

Avidity Partners Management sold out of Sana Biotechnology (SANA) in Q4 2021, closing a stake of 774,644 shares — an estimated $17.4M sold.

Avidity Partners Management first reported a position in SANA in Q1 2021 and held it in 3 quarters. The position peaked at $24.5M in Q1 2021. 105 funds tracked by Wall St. Rank hold SANA as of Q4 2021.

  • Avidity Partners Management reported no remaining Sana Biotechnology position as of Q4 2021 after selling out during the quarter.
  • Avidity Partners Management sold 774,644 Sana Biotechnology shares in Q4 2021, an estimated $17.4M.
  • Avidity Partners Management first reported a position in Sana Biotechnology in Q1 2021 and held it in 3 quarters.
  • Avidity Partners Management's Sana Biotechnology position peaked at $24.5M in Q1 2021.
  • 105 funds tracked by Wall St. Rank held Sana Biotechnology as of Q4 2021.

Based on Avidity Partners Management's 13F filing for Q4 2021, filed 14 Feb 2022.